Clinical Trials Logo

Clinical Trial Summary

Beta-lactam antibiotics include penicillin and cephalosporins and are among the most prescribed antibiotics. This category of drugs is the most involved in immediate allergic manifestations with 2% reactions in treated subjects and a fatal outcome in 1/50000 treatments. Reactions are IgE-mediated and have a considerable but unknown genetic origin, revealed by studies in groups of different ethnical origins in the same geographical region. There are also some families with a high frequency of allergic reactions without identified Mendelian inheritance.

The purpose of this study is to identify predictive risk factors associated to immediate allergic reactions against beta-lactam antibiotics with a pangenomic approach.

A secondary purpose is to identify rare predictive factors with homozygosity mapping and exome sequencing in various families with high risk of allergy to beta-lactam antibiotics.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02895646
Study type Observational
Source Central Hospital, Nancy, France
Contact
Status Active, not recruiting
Phase N/A
Start date June 2012
Completion date June 2017

See also
  Status Clinical Trial Phase
Completed NCT02916888 - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists N/A
Completed NCT02360072 - Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma N/A
Completed NCT02352168 - Airway Inflammation in Children With Allergic Rhinitis and Intervention N/A
Active, not recruiting NCT01904604 - Peanut Epicutaneous Phase II Immunotherapy Clinical Trial Phase 2
Completed NCT01494649 - Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity N/A
Completed NCT00988065 - Sugammadex Hypersensitivity Study (Study P06042) Phase 1
Completed NCT02686827 - DBPC-trial of Subcutaneous Vitamin D3 Comparing Allergic Patients and Healthy Controls. Phase 2
Completed NCT00850668 - Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults Phase 1
Completed NCT00344344 - A Pilot Study to Evaluate the Efficacy of Refined Methods to Mitigate Indoor Allergens in North Carolina and Boston, Massachusetts Homes N/A
Completed NCT02474836 - Determination of Biological Activity of Three Allergen Extracts Phase 2
Completed NCT01731249 - Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis Phase 3
Completed NCT00819494 - Role of Skin Tests for the Diagnosis of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media N/A
Completed NCT01486498 - Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy N/A
Completed NCT00213447 - T Cell Response in Hypersensitivity Syndrome N/A
Recruiting NCT02136576 - Caries Prevention Products & Dentinal Hypersensitivity N/A
Completed NCT01350635 - Skin Test Study of BM32 Phase 1/Phase 2
Completed NCT01040169 - Clinical Efficacy of a Toothpaste on Hypersensitivity Reduction N/A
Completed NCT00461097 - Oral Immunotherapy for Childhood Egg Allergy Phase 2
Completed NCT00001909 - Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma Phase 2
Completed NCT03089788 - Methodological Study to Compare the Effect of Different Methods of Measuring Cat Allergy Symptoms in Patients That Have Immunized Their Cats With FEL-CMV. N/A